Søgeord

Søgning på udtrykket 'hiv' giver 83 resultater

Dokumenter [7] Sider [8] Kalender [27] Nyt fra tidsskrifterne [20] Aktuelle smitsomme sygdomme [20]

Dokumenter [7]

Forfattere: Jan Gerstoft, Nina Weis, Terese L. Katzenstein (Dansk Selskab for Infektionsmedicin), Anders Nyboe Andersen og Jens Fedder (Dansk Fertilitetsselskab).

Endelig guideline: 01.09.2020 Version: 3 Guideline skal revideres senest: 01.09.2023 Arbejdsgruppens medlemmer: Peer Brehm Christensen, Christian Erikstrup, Jan Gerstoft, Terese Katzenstein, Alex Laursen, Suzanne Lunding, Birgitte Mørn og Nina Weis.

PrEP bør overvejes til MSM der ikke er HIV smittede og som regelmæssigt dyrker anal sex uden kondom med forskellige partnere. Udgivet af Dansk Selskab for Infektionsmedicin 2015. Arbejdsgruppen bestod af: Jan Gerstoft, Lars Mathiesen, Jens D. Lundgren, Henrik I. Nielsen, Court Pedersen, Niels Obel og Alex Laursen.

Senest revideret maj 2018. Arbejdsgruppen bestod af: Jan Gerstoft, Gitte Kronborg, Jens D. Lundgren, Henrik I. Nielsen, Olav Ditlevsen Larsen, Niels Obel, Alex Laursen, Ann-Brit Eg Hansen.

Europæisk guideline om hvornår, der bør testes for HIV. Udgivet af "HIV in Europe", et paneuropæisk initiativ for tidligere diagnosticering og behandling af HIV.

Senest revideret marts 2019. Arbejdsgruppen bestod af: Jan Gerstoft, Gitte Kronborg, Ann-Brit Eg Hansen, Jens D. Lundgren, Henrik I. Nielsen, Olav Ditlevsen Larsen, Niels Obel og Alex Laursen.

Anbefaling for profylakse og opfølgning af stikuheld og anden blodeksposition Arbejdsgruppe: Suzanne Lunding (formand), Peer Brehm Christensen, Christian Erikstrup, Terese L. Katzenstein, Henrik Krarup, Alex Lund Laursen, Birgitte Mørn og Nina Weis


Sider [8]

Formål | At kursisten skal opnå en forståelse af HIV-infektionen herunder viden om dens epidemiologi, patogenese, patofysiologi, diagnose, forebyggelse, behandlingsmuligheder og prognose samt viden om diagnostik og behandlingen af AIDS-definerende sygdomme og de hyppigste sexuelt overførte sygdomme. Tid og sted | Hvidovre Hospital. Lokale 10 i undervisningsbygningen Delkursusledere | Ann-Brit Eg Hansen og Ole Kirk Program Mandag 3. oktober | 10:00-10:15 Velkomst og introduktion …

…ologisk terrorisme. Specialet er karakteriseret ved et sygdomspanorama hvor sygdommenes prævalens såvel som incidens ændres hurtigt på lokalt og globalt plan. Over de seneste tyve år har specialet udviklet sig til at håndtere behandlingen af HIV og AIDS. I de seneste år er nye alvorlige infektionssygdomme som SARS, fugleinfluenza, West Nile virus, Hanta virus, Nipah virus, og Hendra virus tilkommet. Alvorlige sygdomme som hæmoragisk viral feber forårsaget af Ebola, Lassa, Dengue, Crimean-Co…

…epræsentanter i diverse arbejdsgrupper og udvalg, og publicerede guidelines. Antiretroviral terapi Henrik Nielsen, Jan Gerstoft, Jens Lundgren, Alex Laursen, Niels Obel, Olav Larsen, Gitte Kronborg, Ann-Brit Eg Hansen Antiviral behandling af hiv smittede personer Fertilitetsbehandling ved HIV og hepatitis B og C HIV behandling af gravide HIV post exposure profylakse (PEP) Pre-exposure profylakse mod HIV (PrEP) Borrelia Anne-Mette Lebech, Sigurdur Skarphedinsson Borrelia klar…

…nfektioner og kronisk hepatitis | Dato for næste kursus Efterår 2023 | Sted | Hvidovre Hospital | Delkursusledelse | Morten HelmsPeer Brehm Christensen  | Tidligere kurser | 3. og 4. december 2020 HIV-infektion | Dato for næste kursus Oktober 2022 (2 dage) | Sted | Endnu ikke afklaret | Delkursusledelse |   | Tidligere kurser | 7. og 8. oktober 2019 | 3. og 4. oktober 2016 Immundefekt og fe…

…ologisk terrorisme. Specialet er karakteriseret ved et sygdomspanorama hvor sygdommenes prævalens såvel som incidens ændres hurtigt på lokalt og globalt plan. Over de seneste tyve år har specialet udviklet sig til at håndtere behandlingen af HIV og AIDS. I de seneste år er nye alvorlige infektionssygdomme som SARS, fugleinfluenza, West Nile virus, Hanta virus, Nipah virus, og Hendra virus tilkommet. Alvorlige sygdomme som hæmoragisk viral feber forårsaget af Ebola, Lassa, Dengue, Crimean-Co…

Formål | At kursisten skal opnå en forståelse af HIV-infektionen herunder viden om dens epidemiologi, patogenese, patofysiologi, diagnose, forebyggelse, behandlingsmuligheder og prognose samt viden om diagnostik og behandlingen af AIDS-definerende sygdomme og de hyppigste sexuelt overførte sygdomme. Tid og sted | Hvidovre Hospital. Lokale 10 i undervisningsbygningen Delkursusledere | Ann-Brit Eg Hansen og Ole Kirk Program Mandag 3. oktober | 10:00-10:15 Velkomst og introduktion …

Formål | Rejsefondens formål er at yde økonomisk støtte til lægelige medlemmer af DSI med henblik på deltagelse på følgende kongresser: NSCMID, ECCMID, IDWeek, HIV og Hepatitis Nordic Conference, EACS/Glasgow HIV og CROI. | Hvad kan der søges om? | Der kan søges om økonomisk støtte til registreringsafgift, rejseudgifter og indlogering til de respektive kongresser. Det er ikke et krav at man har et videnskabeligt bidrag på kongressen. | Man kan højest få tildelt støtte til…


Kalender [27]

30.09.2021, Barcelona, Spanien
28.10.2020, Paris, Frankrig
25.10.2020, Glasgow, Skotland
13.05.2019, København, Odense, Aarhus
28.10.2018, Glasgow, Skotland
30.05.2018, Aarhus Universitshospital Skejby, gæstekantinen ved hovedindgangen, Palle Juul-Jensens Blvd. 99, Aarhus N
30.05.2018, Rom, Italien
25.04.2018, CHIP, Øster Allé 56, 5. sal (Persimune mødelokale), 2100 København Ø
16.03.2018, Værløse
8.06.2017, Hvidovre Hospital
23.10.2016, Glasgow, Skotland
3.10.2016, Hvidovre Hospital
3.06.2015, Barcelona, Spanien
2.11.2014, Glasgow, Skotland
22.04.2014, Auditorium 5, Hvidovre Hospital
26.03.2014, Barcelona, Spanien
20.03.2013, Rom, Italien
14.01.2013, Auditorium 2, Rigshospitalet

Nyt fra tidsskrifterne [20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
PLoS One Infectious Diseases
26.07.2021
…es, Fernando Braz Pauli, Samyra Soligo Rovani, Franciele Aní Caovilla Follador, Ana Paula Vieira, Renata Himovski Torres, Harnoldo Colares Coelho, Guilherme Welter Wendt The prevalence of hepatitis C virus (HCV) and the acquired immunodeficiency virus (HIV) is much higher in prisons than in community settings. Some explanatory factors for this burden include putative aspects of the prison environment, such as unprotected sexual relations and sexual violence, use of injectable drugs and syringe sharing. N…
PLoS One Infectious Diseases
26.07.2021
…berculosis at the point-of-care (POC) is limited by the low sensitivity of current commercially available tests. We describe a diagnostic accuracy field evaluation of a prototype urine Tuberculosis Lipoarabinomannan Lateral Flow Assay (TB-LAM LFA) in both HIV-positive and HIV-negative patients using fresh samples with sensitivity and specificity as the measures of accuracy. This prototype combines a proprietary concentration system with a sensitive LFA. In a prospective study of 292 patients with suspected …
Emerging Infectious Diseases
23.07.2021
S. A. Hoffman et al.
Emerging Infectious Diseases
22.07.2021
S. A. Hoffman et al.
PLoS One Infectious Diseases
21.07.2021
by Eleanor E. Friedman, Samantha A. Devlin, Moira C. McNulty, Jessica P. Ridgway Since the onset of the COVID-19 pandemic, it has been unclear how vulnerable people with HIV (PwH) are to SARS-CoV-2 infection. We sought to determine if PwH are more likely to test positive for SARS-CoV-2 than people without HIV, and to identify risk factors associated with SARS-CoV-2 positivity among PwH. We conducted a cross-sectional study in which we collected electronic medical record data for all patients who underwent…
New England Journal of Medicine
21.07.2021
New England Journal of Medicine, Volume 385, Issue 4, Page 330-341, July 2021.
BMC Infectious Diseases
21.07.2021
Abstract Background Methadone therapy clinics have been recently introduced in Tanzania, aiming at reducing risk behaviors and infection rates of viral hepatitis and HIV among people who use drugs. The objective of this study was to estimate the prevalence, associated factors and knowledge level of these conditions among people who use drugs attending a methadone clinic in Tanzania. …
BMC Infectious Diseases
20.07.2021
Abstract Background Support groups for people living with HIV (PLWH) may improve HIV care adherence and outcomes. We assessed the impact of support group attendance on antiretroviral therapy (ART) adherence and viral suppression in four African countries. Methods The ongoing African Cohort Study (AFRICOS) enrolls participants at 12 clinics in Kenya, Uganda, …
Journal of Acquired Immune Deficiency Syndromes
19.07.2021
…reatment-experienced patients with antiretroviral resistance receiving BIC/FTC/TAF plus a boosted protease inhibitor. Setting/Methods: This prospective, single-center, non-randomized pharmacokinetic study enrolled adult treatment-experienced persons with HIV and creatinine clearance > 30 mL/min receiving BIC/FTC/TAF + DRV/c as part of routine clinical care. Steady-state PK profiles of BIC, TAF, TFV and DRV following daily dosing of BIC/FTC/TAF + DRV/c were obtained with samples at pre-dose and 0.5, 1, 2 an…
Journal of Acquired Immune Deficiency Syndromes
19.07.2021
No abstract available
Journal of Acquired Immune Deficiency Syndromes
19.07.2021
Background: Older adults with HIV (OAH) experience more comorbidities and geriatric syndromes than their HIV-negative peers, perhaps due to chronic inflammation. Cell-free mitochondrial DNA (cfmtDNA) released from cells undergoing necrosis-mediated cell death potentially acts as both a mediator and marker of inflammatory dysregulation. We hypothesized that urinary cfmtDNA would be associated with frailty, body composition and fall history in OAH Methods: OAH completed frailty testing, a psychosocial su…
PLoS One Infectious Diseases
16.07.2021
by Jan W. de Lind van Wijngaarden, Frits van Griensven, Ly Penh Sun, Stephen Wignall Background Cambodia is widely credited for its successful HIV epidemic control. However, in recent years there have been signs of increasing HIV prevalence among men who have sex with men (MSM) and transgender women (TGW). This paper reviews HIV epidemiological, social science and HIV program implementation studies conducted over the past 20 years to explore possible reasons for the rising HIV prevalence among these groups…
PLoS One Infectious Diseases
16.07.2021
…e TST positive and the median MLR was 0.18 (IQR 0.13–0.28). The MLR distribution differed between CD4 count categories (p < 0.01), with a broader range of values in TST negative participants with a low CD4 count (≤ 250 cells/mm3), likely reflecting HIV immunosuppression. MLR was associated with a positive TST (OR 0.78 per 0.1 increase, 95% CI 0.59, 0.97) in bivariate analysis but not in multivariate regression analysis (aOR 0.83 for every 0.1 increase, 95% CI 0.60, 1.08). Conclusion In ART-naïve ad…
AIDS
16.07.2021
Objective: To assess failure after treatment of high-grade cervical intraepithelial neoplasia (CIN2+) by HIV status and HPV type Design: Population-based register study Methods: The Swedish National HIV Registry, the Swedish Population Registry and the Swedish National Cervical Screening Registry were linked to identify all women in Stockholm and Gothenburg counties (Sweden) living with HIV and diagnosed with CIN2+ sometime between 1983 and 2014 (n = 179). HIV-negative controls with CIN2+, were …
AIDS
16.07.2021
Objective: In the United States (US), HIV pre-exposure prophylaxis (PrEP) use is suboptimal. Population-level metrics on PrEP use are limited and focus on prescriptions issued rather than how much prescriptions are picked up. We introduce PrEP reversals, defined as when patients fail to pick up PrEP prescriptions at the pharmacy point-of-sale, as a proxy for PrEP initiation and persistence. Design: We analyzed PrEP pharmacy claims and HIV diagnoses from a Symphony Health Solutions dataset across all US…
Tropical Medicine & International Health
15.07.2021
Tropical Medicine & International Health, Accepted Article.
Journal of Medical Virology
14.07.2021
Journal of Medical Virology, Accepted Article.
Journal of Acquired Immune Deficiency Syndromes
14.07.2021
Background. Adherence to antiretroviral therapy (ART) and sustained HIV suppression virtually eliminates HIV transmission, e.g., having an undetectable viral load renders HIV untransmittable (U=U). Due to the greatly reduced likelihood of HIV transmission when viral load is undetectable, we studied one behavioral ramification of adopting a U=U prevention strategy - not disclosing HIV status to sex partners. Setting: Cisgender men recruited through community outreach in the state of Georgia, USA. Metho…
Journal of Acquired Immune Deficiency Syndromes
14.07.2021
The recent global pandemic of coronavirus disease-19, also known as COVID-19, has posed significant challenges to Emergency Department (ED) HIV and HCV screening programs as well as linkage to care efforts in those identified with HIV or HCV infections. The goal of this educational report was to describe challenges in the face of the COVID-19 pandemic and solutions, focusing on our HIV and HCV opt-out universal ED screening program at the University of California San Diego (UCSD) Medical Center, San Diego, …

Aktuelle smitsomme sygdomme [20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
Medscape Infectious Diseases
20.07.2021
Side effects from once-daily islatravir plus doravirine are short-lived and mild.
Medscape Infectious Diseases
13.07.2021
As the world begins to make sense of the impact of COVID-19 on health, HIV researchers get back to the work of optimizing treatments and tackling the structural barriers that keep patients sick.
Medscape Infectious Diseases
6.07.2021
Aid agencies have distributed a strawberry-flavoured tablet for children living with HIV in six African countries, the first generic pediatric version of a key antiretroviral, global health agency UNITAID said on Sunday.
Morbidity and Mortality Weekly Report (MMWR)
1.07.2021
Male circumcision is an important preventive strategy in lifelong partial protection against heterosexually acquired HIV infection among males. This report describes how the prevalence of male circumcision increased in Chókwè District in southern Mozambique.
Morbidity and Mortality Weekly Report (MMWR)
24.06.2021
This report describes HIV testing trends in people with commercial insurance or Medicaid.
Eurosurveillance latest updates
24.06.2021
Background Recent and reliable estimates on the prevalence of coinfection with human immunodeficiency virus (HIV) and hepatitis B virus (HBV) in Europe are lacking. Aim Leveraged on a study designed to assess HIV/HCV coinfection prevalence, we assessed the prevalence of HIV/HBV coinfection in Spain in 2018 and compared the results with five similar studies performed since 2002. Methods This cross-sectional prevalence study was carried out in 43 centres, and patients were selected using simple random s…
ProMED
15.06.2021
Other Human Disease -- South AfricaAbstract--------An HIV-positive man from Zimbabwe living in South Africa sought treatment for multiple clinical signs, including fever, weight loss, anemia, and splenomegaly. We identified in his blood an African rodent piroplasm, _Anthemosoma garnhami_, related to _Babesia_ species. This finding extends the known geographic and host range of _A. garnhami_. A 24-year-old man from Zimbabwe complaining of a 3-month period of generalized body pains, drenching night sweats, an…
Medscape Infectious Diseases
11.06.2021
Despite significant advances in HIV research, prevention, and treatment, HIV is still criminalized both in the U.S. and abroad. Is this the ultimate challenge to ending the epidemic?
Eurosurveillance latest updates
10.06.2021
Human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP), the use of antiretroviral medication to prevent HIV acquisition, is a highly effective biomedical prevention tool. The World Health Organization (WHO) recommends PrEP for people at substantial risk of HIV infection, as part of combination prevention, and highlights the need for robust evaluation of PrEP programmes. Based on suggested WHO core indicators, we created a concise set of HIV PrEP-related dataset variables, to harmonise the monito…
Morbidity and Mortality Weekly Report (MMWR)
3.06.2021
This report describes how HIV-positive patients with severe HIV disease were more likely to develop severe COVID-19 or die of COVID-19.
Morbidity and Mortality Weekly Report (MMWR)
3.06.2021
This report describes estimated HIV infections in the United States during 1981-2019.
Morbidity and Mortality Weekly Report (MMWR)
27.05.2021
This report describes the impact of COVID-19 on HIV viral load testing in PEPFAR-supported countries.
Morbidity and Mortality Weekly Report (MMWR)
27.05.2021
This report describes how Sub-Saharan African countries have overcome challenges to initiate and scale up HIV viral load testing to monitor patients receiving Antiretroviral therapy.
ProMED
2.05.2021
HIV/AIDS -- United States"Lowering the number of new HIV infections among transgender women is a major HIV prevention goal [1]. This goal can be achieved by implementing 3 important strategies for reducing HIV infections: (1) intensifying HIV prevention efforts in populations where HIV is most heavily concentrated, including transgender women; gay, bisexual, and other men who have sex with men (hereafter referred to as MSM); black or African American persons; Hispanic or Latino persons; and persons who inje…
Medscape Infectious Diseases
21.04.2021
Public health resources have shifted from one pandemic to the other, and experts fear steep declines in testing and diagnoses mean more people will contract HIV and die of AIDS.
Medscape Infectious Diseases
20.04.2021
A decline in slow wave activity during nonrapid eye movement sleep had previously been associated with markers of brain aging in healthy adults.
Medscape Infectious Diseases
19.04.2021
Nearly 1 in 10 Southern men who have sex with men discontinued HIV PrEP in early COVID, but those who continued to take it did so consistently.
Medscape Infectious Diseases
15.04.2021
We owe these early fighters a debt of gratitude for transforming our response to public health crises.
Medscape Infectious Diseases
6.04.2021
West Virginia Sen. Joe Manchin asked for an inquiry on behalf of the Kanawha County Commission 2 months after a CDC official warned that the county's outbreak was 'the most concerning in the US.'
Medscape Infectious Diseases
18.03.2021
The phase 2b study lays out a path toward developing monoclonal antibody drugs for passive prevention of HIV. It also paves the way toward developing a biomarker for predicting success.

Nyhedsbrev

Skriv din email adresse og modtag nyheder om hjemmesiden.


© 2021 Dansk Selskab for Infektionsmedicin

version: 2.9.0 ● design: C P Fischer

Side indlæst på 0,582 s

Cookies og privatliv